We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$121B
AUM Growth
+$9.79B
Cap. Flow
-$942M
Cap. Flow %
-0.78%
Top 10 Hldgs %
9.24%
Holding
5,958
New
1,032
Increased
1,969
Reduced
1,595
Closed
616

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$986M
2
SE icon
Sea Limited
SE
+$480M
3
SNOW icon
Snowflake
SNOW
+$441M
4
C icon
Citigroup
C
+$422M
5
ORCL icon
Oracle
ORCL
+$393M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$575M
2
AAPL icon
Apple
AAPL
+$515M
3
MA icon
Mastercard
MA
+$506M
4
DIS icon
Walt Disney
DIS
+$447M
5
BABA icon
Alibaba
BABA
+$434M

Sector Composition

Rank Sector Weight
1 Technology 13.97%
2 Consumer Discretionary 9.19%
3 Financials 7.48%
4 Healthcare 7.05%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTBP icon
4851
GT Biopharma
GTBP
$13.8M
$129K ﹤0.01%
1,413
-2,783
-66% -$416K
IFRX icon
4852
InflaRx
IFRX
$302M
$129K ﹤0.01%
+27,053
New +$109K
GYRE icon
4853
Gyre Therapeutics
GYRE
$683M
$128K ﹤0.01%
+18,691
New +$320K
PRTK
4854
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$128K ﹤0.01%
28,413
-27,094
-49% -$129K
SGTX
4855
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$128K ﹤0.01%
+3,557
New +$202K
THACW
4856
DELISTED
Thrive Acquisition Corporation Warrant
THACW
$128K ﹤0.01%
+257,500
New +$117K
UHGWW
4857
DELISTED
United Homes Group Warrant
UHGWW
$127K ﹤0.01%
213,580
IPOD.WS
4858
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$127K ﹤0.01%
62,500
ADMA icon
4859
ADMA Biologics
ADMA
$2.14B
$126K ﹤0.01%
+89,307
New +$117K
CECO icon
4860
Ceco Environmental
CECO
$4.18B
$126K ﹤0.01%
20,160
+2,350
+13% +$15.6K
CLBT icon
4861
Cellebrite
CLBT
$2.88B
$126K ﹤0.01%
+15,744
New +$148K
ARGUW
4862
DELISTED
Argus Capital Corp. Warrant
ARGUW
$126K ﹤0.01%
+233,333
New +$141K
ACRO.WS
4863
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$125K ﹤0.01%
149,999
ORN icon
4864
Orion Group Holdings
ORN
$369M
$124K ﹤0.01%
32,802
-16,461
-33% -$73.2K
QUBT icon
4865
Quantum Computing Inc
QUBT
$1.87B
$124K ﹤0.01%
+36,342
New +$193K
TG icon
4866
Tredegar Corp
TG
$278M
$124K ﹤0.01%
+10,506
New +$127K
BTU icon
4867
PUT
Peabody Energy
BTU
$3.4B
$123K ﹤0.01%
12,200
-7,100
-37% -$86.2K
XBIT icon
4868
XBiotech
XBIT
$70.4M
$123K ﹤0.01%
11,042
-5,240
-32% -$68.2K
PL.WS
4869
DELISTED
Planet Labs PBC Warrants
PL.WS
$122K ﹤0.01%
+62,598
New +$137K
PROF
4870
Profound Medical
PROF
$248M
$121K ﹤0.01%
+10,715
New +$134K
BFX
4871
CALL
DELISTED
BowFlex Inc.
BFX
$121K ﹤0.01%
+19,800
New +$164K
WPCB.WS
4872
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$121K ﹤0.01%
120,750
FSNB.WS
4873
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
$121K ﹤0.01%
201,354
LMPX
4874
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
$121K ﹤0.01%
+17,254
New +$202K
AQB icon
4875
AquaBounty Technologies
AQB
$6.74M
$120K ﹤0.01%
+2,867
New +$185K

Similar funds

David Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, David Shaw held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw's Q4 2021 filing shows 1,032 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

  • David Shaw's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
  • David Shaw added most to Sea Limited in Q4 2021, an estimated $480M increase.
  • David Shaw's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
  • David Shaw fully exited Aon in Q4 2021, selling an estimated $179M.
  • David Shaw's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
  • David Shaw opened 1,032 new positions and closed 616 in Q4 2021.
  • David Shaw's portfolio value rose 8.8% quarter-over-quarter to $121B.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.